Latest Breaking News On - Vikram narayan - Page 1 : comparemela.com

Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC

Nadofaragene firadenovec led to durable antitumor activity in BCG-unresponsive NMIBC either with CIS or papillary disease, according to 5-year data from the phase 3 Study CS-003.

United statesVikram narayanAmerican urological association annual meetingFerring pharmaceuticalsUrological association annualUrological oncologyGrady memorial hospitalEmory university schoolWinship cancerBacillus calmette guUrothelial cancer

Dr Narayan on the Mechanism of Action of Nadofaragene Firadenovec in NMIBC

Vikram Narayan, MD, discusses the mechanism of action of nadofaragene firadenovec in patients with high-risk non–muscle invasive bladder cancer.

Vikram narayanDepartment of urologyEmory university school of medicineWinship cancer instituteUrological oncologyGrady memorial hospitalEmory university schoolUrothelial cancerWinship cancer institute of emory universityOnclive tv

Narayan Details How Nadofaragene Firadenovec Has Broken Ground as the First Gene Therapy for NMIBC

Narayan Details How Nadofaragene Firadenovec Has Broken Ground as the First Gene Therapy for NMIBC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Grady memorial hospitalUnited statesVikram narayanAmerican urological associationSociety of urologic oncology clinical trials consortiumUrological oncologyEmory university schoolWinship cancer instituteUrologic oncology clinical trials consortium